Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

All Articles

National Cancer Prevention Month
February is National Cancer Prevention Month! Check out this slideshow full of information relating to the detection and prevention of cancer, including the 4 leading causes of cancer in the US. Conquer cancer with knowledge. Read More ›

Common Cancer Myths and Misconceptions
Do cell phones cause cancer? Does deodorant cause breast cancer? These common myths and more explored in this slideshow. Read More ›

A Novel Tissue Expander System Offers New Options in Breast Reconstruction
For the first time in 40 years, patients who are considering reconstructive surgery after a mastectomy because of breast cancer have a new option for tissue expansion—the AeroForm Tissue Expander System. Read More ›

Stivarga and Opdivo Newest Treatments for Liver Cancer
In 2017, the FDA approved two new treatments for patients with hepatocellular carcinoma (HCC), Stivarga and Opdivo. Read about these new treatments for liver cancer. Read More ›

Alecensa a New First-Line Treatment for Lung Cancer with ALK Mutation
In November 2017, the FDA approved Alecensa for the treatment of all patients with metastatic non–small-cell lung cancer (NSCLC) and ALK mutation. Read More ›

Calquence Newest Treatment Approved for Mantle-Cell Lymphoma
In October 2017, the FDA accelerated the approval of Calquence for the treatment of adults with mantle-cell lymphoma who have received at least 1 previous therapy. Read More ›

Verzenio a New Targeted Therapy Approved for Metastatic Breast Cancer
Read about Verzenio, which was approved by the FDA in 2017, in combination with fulvestrant, for treatment of women with HR-positive, HER2-positive, HER2-negative advanced, or metastatic breast cancer that progressed after endocrine therapy. Read More ›

Aliqopa the Newest Treatment Approved for Relapsed Follicular Lymphoma

Actemra First Treatment Approved for CAR T-Cell–Induced Cytokine-Release Syndrome

Besponsa a New Treatment Option for Patients with Relapsed/Refractory B-Cell ALL

Page 123 of 163